Busulfex and anorexia 
Busulfex and anorexia Patient Reports February 13, 2012
Busulfex Side Effects Report #5767002-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on May 27, 2008. Female patient, child 9 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, diarrhoea, febrile neutropenia, gamma-glutamyltransferase increased, hyperbilirubinaemia, hypokalaemia. Busulfex dosage: 26 ML; INTRAVENOUS. During the same period patient was treated with MELPHALAN, CLONAZEPAM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5819581-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Female patient, child 9 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anorexia, bone marrow transplant
, condition aggravated, cystitis haemorrhagic, diarrhoea, malaise, nausea , stomatitis. Busulfex dosage: 11.1 ML, INTRAVENOUS, 14.8 ML DAILY DOSE; INTRAVENOUS, 3.7 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE, MELPHALAN, ETOPOSIDE, VALPROATE, METHOTREXATE, TACROLIMIS. Patient died.Busulfex Side Effects Report #5832013-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 16, 2008. Female patient, child 9 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, febrile neutropenia, gamma-glutamyltransferase increased, hyperbilirubinaemia, hypokalaemia. Busulfex dosage: 26 ML. During the same period patient was treated with MELPHALAN, CLONAZEPAM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5849766-4
Busulfex side effect was reported by a Health Professional from JAPAN on Aug 08, 2008. Male patient, child 9 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, gastritis, hypercalcaemia, infection
, liver disorder, nausea , occult blood, venoocclusive liver disease. Busulfex dosage: 18.4 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, TACROLIMUS, METHOTREXATE. Patient recovered.Busulfex Side Effects Report #5803072-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Male patient, child 8 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, convulsion, diarrhoea, escherichia infection, febrile neutropenia, graft versus host disease, liver function test abnormal, malaise, stomatitis. Busulfex dosage: 10 ML, INTRAVENOUS. During the same period patient was treated with ANTILYMPHOCYTE IMMUNOGLOBULIN, FLUDARABINE PHOSPHATE, VALPROATE, MIDAZOLAM. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5877536-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Male patient, child 8 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, convulsion, diarrhoea, escherichia infection, febrile convulsion, febrile neutropenia, hepatic function abnormal, malaise. Busulfex dosage: 10 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, VALPROATE, MIDAZOLAM, ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, METHYLPREDNISOLONE, LENOGRASTIM. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5871281-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 19, 2008. Male patient, child 7 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant
, cystitis haemorrhagic, diarrhoea, malaise, nausea , sepsis , stomatitis. Busulfex dosage: 68 ML INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, LENOGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5887491-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Male patient, child 7 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, coagulopathy, dehydration, febrile neutropenia, gastritis, haemosiderosis, hepatic failure, hepatic function abnormal, hyperbilirubinaemia. Busulfex dosage: 11.6 ML, INTRAVENOUS. During the same period patient was treated with MELPHALAN, CLONAZEPAM, FILGRASTIM. Patient was hospitalized. Patient died on 11/29/2007.
Busulfex Side Effects Report #5819493-8
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 69 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, jaundice cholestatic, malaise, nausea
, stomatitis. Busulfex dosage: 30 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHSOPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACTROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5743646-0
Busulfex side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute respiratory failure, anorexia, cytomegalovirus viraemia, diarrhoea, enterobacter sepsis, malaise, nausea
, renal failure acute, thrombocytopenia. Busulfex dosage: 24 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5811841-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, staphylococcal sepsis. Busulfex dosage: 32 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5819440-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2008. Male patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, chest discomfort, constipation
, convulsion, diarrhoea, encephalitis , erythema, malaise, oedema. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died on 03/11/2007.Busulfex Side Effects Report #5886252-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 01, 2008. Male patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, chest discomfort, constipation
, convulsion, diarrhoea, encephalitis viral, erythema, malaise, oedema. Busulfex dosage: 30 ML INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5902789-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 17, 2008. Female patient, 67 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal pain upper, acute respiratory failure, anorexia, blood bilirubin increased, bone marrow transplant
, bone marrow transplant rejection, cytomegalovirus viraemia, diarrhoea, enterobacter sepsis. Busulfex dosage: 24 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5819582-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 66 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cystitis, cytomegalovirus enterocolitis, diarrhoea, graft versus host disease, interstitial lung disease, malaise, nausea
. Busulfex dosage: 25.5 ML; INTRAVENOUS, 34 ML, DAILY DOSE; INTRAVENOUS, 8.5 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, FILGRASTIM, TACROLIMIS. Patient died.Busulfex Side Effects Report #5729828-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 65 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood pressure decreased, bronchiectasis, depressed level of consciousness, diarrhoea, engraftment syndrome, heart rate decreased, interstitial lung disease, jaundice
. Busulfex dosage: ML, INTRAVENOUS, 20 ML,. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, METHOTREXATE, TACROLIMUS, NEUPOGEN. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5886951-X
Busulfex side effect was reported by a Health Professional from JAPAN on Sept 02, 2008. Male patient, 65 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, graft versus host disease, malignant neoplasm progression, stomatitis. Busulfex dosage: 32 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #6030743-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 24, 2008. Male patient, 65 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant
, bone marrow transplant rejection, disease recurrence, malignant neoplasm progression, platelet count decreased, pneumonia , stomatitis. Busulfex dosage: 8 ML, QID INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died on 01/05/2008.Busulfex Side Effects Report #5800909-8
Busulfex side effect was reported by a Physician from JAPAN on June 20, 2008. Male patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, atrial tachycardia, atrioventricular block, bone marrow transplant
, cytomegalovirus viraemia, diarrhoea, dysgeusia. Busulfex dosage: unknown. During the same period patient was treated with PHENYTOIN, NARTOGRASTIM, METHOTREXATE, TACROLIMUS, CYTARABINE, NOVANTRONE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5857246-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 30, 2008. Female patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease in skin, acute respiratory distress syndrome, anorexia, blood bilirubin increased, bone marrow transplant rejection, bronchoalveolar lavage abnormal, candidiasis, convulsion, diarrhoea. Busulfex dosage: 5 ML, INTRAVENOUS;10 ML, INTRAVENOUS; 20 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NARTOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died.
Busulfex Side Effects Report #5888931-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute respiratory distress syndrome, anorexia, blood bilirubin increased, bone marrow transplant rejection, candida pneumonia, convulsion, diarrhoea, disseminated intravascular coagulation. Busulfex dosage: 5 ML, DAILY DOSE INTRAVENOUS; 10 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FOSCARNET, FLUDARABINE PHOSPHATE, VALPROATE, NARTOGRASTIM, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died on 10/14/2007.
Busulfex Side Effects Report #5989586-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2008. Male patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood culture positive, blood pressure decreased, cellulitis
, diarrhoea, haemodialysis, hepatic function abnormal, lobar pneumonia, malaise. Busulfex dosage: 2.4 ML 0.8 ML, QID, INTRAVENOUS. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, FLUDARABINE PHOSPHATE, LORAZEPAM, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient died on 11/27/2007.Busulfex Side Effects Report #5990194-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2008. Female patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, cardiac failure chronic, disease recurrence, febrile neutropenia, hypoaesthesia, hypokalaemia, hyponatraemia, malaise. Busulfex dosage: 6.6 ML, TID. During the same period patient was treated with FLUDARABINE PHOSPHATE, DEPAKENE, ANTILYMPHOCYTE IMMUNOGLOBULIN, FILGRASTIM, METHOTREXATE, TACROLIMUS, VANCOMYCIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #6053557-1
Busulfex side effect was reported by a Health Professional from JAPAN on Jan 14, 2009. Female patient, 64 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant rejection, chronic graft versus host disease, diarrhoea, febrile neutropenia, gamma-glutamyltransferase increased, malaise, nausea
. Busulfex dosage: 4.8 ML, TID; 4.8 ML, QID; 4.8 ML, QD. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, PHENYTOIN, DEPAKENE, LENOGRASTIM, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5786817-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 09, 2008. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, headache
, malaise, nausea , oedema, pain in extremity, pneumonia . Busulfex dosage: 30 ML. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5878607-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, headache
, malaise, nausea , oedema, pain in extremity, pneumonia . Busulfex dosage: 30 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5972679-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 13, 2008. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, graft versus host disease, headache
, malaise, nausea , oedema, pain in extremity, pneumonia . Busulfex dosage: 30 ML, DAILY DOSE. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died on 10/16/2007.Busulfex Side Effects Report #5769154-9
Busulfex side effect was reported by a Physician from JAPAN on May 29, 2008. Female patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, cytomegalovirus infection , enterocolitis viral, graft versus host disease, pneumonia , stomatitis. Busulfex dosage: 28 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5819491-4
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, enterococcal sepsis, malaise, nausea
, stomatitis, treatment failure. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.Busulfex Side Effects Report #5877275-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 27, 2008. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, enterococcal sepsis, leukaemia recurrent, malaise, nausea
, stomatitis. Busulfex dosage: 30 ML, UNK, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient died on 05/15/2007.Busulfex Side Effects Report #5989256-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2008. Male patient, 61 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal distension, acute graft versus host disease, acute graft versus host disease in skin, anorexia, cellulitis
, diarrhoea, escherichia infection, escherichia sepsis, ileus. Busulfex dosage: 27 ML, INTRAVENOUS; 9 ML, QID; INTRAVENOUS; 9 ML, QD; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5743657-5
Busulfex side effect was reported by a Health Professional from JAPAN on May 08, 2008. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, anorexia, bone marrow transplant
, cytomegalovirus antigen positive, cytomegalovirus viraemia, graft versus host disease, liver disorder, nausea , nystagmus. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5812208-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, catheter related infection, cytomegalovirus viraemia, diarrhoea, enterocolitis bacterial, nausea
, stomatitis. Busulfex dosage: 31.48 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #6065316-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 20, 2009. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, blood sodium decreased, bone marrow transplant rejection, cardiovascular disorder, diarrhoea, escherichia sepsis, febrile neutropenia, haemodialysis. Busulfex dosage: 9 ML, TID INTRAVENOUS ; 9 ML QID; INTRAVENOUS ; 9 ML, QD; INTRAVENOUS. During the same period patient was treated with VALPROATE, CYTARABINE, FLUDARABINE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died on 06/26/2007.
Busulfex Side Effects Report #5822822-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Female patient, child 6 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, febrile neutropenia, malaise, stomatitis. Busulfex dosage: 72 MG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, MELPHALAN, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5698125-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 20, 2008. Male patient, 59 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood pressure decreased, capillary leak syndrome, cardiac arrest
, condition aggravated, disease progression, disseminated intravascular coagulation. Busulfex dosage: 30.8 ML, INTRAVENOUS. Patient died on 03/01/2007.Busulfex Side Effects Report #5849536-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 08, 2008. Female patient, 59 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, cytomegalovirus viraemia, diarrhoea, hypocalcaemia, malaise, platelet count decreased, renal failure acute. Busulfex dosage: 14 ML, DAILY DOSE INTRAVENOUS; 28 ML, DAILY DOSE; INTRAVENOUS; DAILY DOSE; INTRAVENOUS. During the same period patient was treated with PHENYTOIN, MELPHALAN, CYCLOSPORINE. Patient was hospitalized. Patient died on 09/07/2007.
Busulfex Side Effects Report #5894817-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 11, 2008. Male patient, 59 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, aspergillosis, cytomegalovirus viraemia, diarrhoea, interstitial lung disease, malaise, nausea
, oropharyngeal pain, pruritus. Busulfex dosage: 184 MG, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, FILGRASTIM. Patient died on 10/28/2007.Busulfex Side Effects Report #5729833-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anaemia, anorexia, blast cell count increased, blood bilirubin increased, condition aggravated, cytomegalovirus viraemia, graft complication, haematemesis. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, TACROLIMUS, NEUPOGEN, VALPROATE, METHOTREXATE. Patient was hospitalized. Patient died on 05/01/2007.
Busulfex Side Effects Report #5729836-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, cerebral haemorrhage, diarrhoea, malaise, multi-organ failure, pneumonia , sepsis , shock. Busulfex dosage: 33.2 ML INTRAVENOUS; 16.6 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, METHOTREXATE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5798835-6
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, enterocolitis, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG INTRAVENOUS. During the same period patient was treated with PHENYTOIN, NEUPOGEN, MITOXANTRONE HYDROCHLORIDE, METHOTREXATE, CYCLOSPORINE, MITOXANTRONE HYDROCHLORIDE. Patient died.Busulfex Side Effects Report #5809438-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus colitis, diarrhoea, febrile neutropenia, malaise, nausea
. Busulfex dosage: 15.2 ML, DAILY DOSE, INTRAVENOUS; 20 ML, DAILY DOSE; INTRAVENOUS; 40 ML; DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5834906-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2007. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, gamma-glutamyltransferase increased, staphylococcal sepsis, stomatitis. Busulfex dosage: 27 ML, INTRAVENOUS ; 36 ML, DAILY DOSE; INTRAVENOUS ; 9 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FILGRASTIM, VALPROATE, FLUDARABINE PHOSPHATE, METHOTREXATE, CYCLOSPORINE, FOSCARNET. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5883707-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 27, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood potassium decreased, blood urea increased, bone marrow transplant
, cerebral haemorrhage. Busulfex dosage: 33.2 ML, DAILY DOSE INTRAVENOUS; 16.6 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, METHOTREXATE. Patient was hospitalized. Patient died on 11/30/2007.Busulfex Side Effects Report #5989584-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, cytomegalovirus colitis, diarrhoea, febrile neutropenia, malaise, nausea
, stem cell transplant. Busulfex dosage: 15.2 ML, DAILY DOSE. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5990196-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 01, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, diarrhoea, enterocolitis viral, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG. During the same period patient was treated with METHOTREXATE, MITOXANTRONE HYDROCHLORIDE, FLUDARABINE PHOSPHATE, PHENYTOIN, FILGRASTIM, CYCLOSPORINE. Patient died.Busulfex Side Effects Report #6060141-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2009. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, enterocolitis viral, febrile neutropenia, graft versus host disease, malaise, nausea
, stomatitis. Busulfex dosage: 460 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, CYCLOSPORINE, MITOXANTRONE HYDROCHLORIDE, FLUDARABINE PHOSPHATE, PHENYTOIN, FILGRASTIM. Patient died on 11/18/2007.Busulfex Side Effects Report #6076402-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 28, 2009. Female patient, 58 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, blood triglycerides increased, bone marrow transplant rejection. Busulfex dosage: 6.7 ML, QID INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient died on 10/11/2007.
Busulfex Side Effects Report #5743637-X
Busulfex side effect was reported by a Health Professional from JAPAN on May 08, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, alanine aminotransferase increased, anorexia, blood bilirubin increased, bone marrow transplant
, bone marrow transplant rejection, platelet count decreased, sepsis . Busulfex dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5782929-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 11, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, malaise, nausea , sepsis . Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with MELPHALAN. Patient died on 07/19/2006.Busulfex Side Effects Report #5872400-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 20, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, bone marrow transplant
, diarrhoea, febrile neutropenia, malaise, nausea , reticulocyte count decreased, stomatitis. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient died.Busulfex Side Effects Report #5893736-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bacterial sepsis, malaise, pseudomonal sepsis, septic shock, stomatitis. Busulfex dosage: 12.8 MG/KG, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, FILGRASTIM. Patient died.
Busulfex Side Effects Report #5893737-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, candida sepsis, cytomegalovirus viraemia, disseminated intravascular coagulation, histiocytosis haematophagic, nausea
, stem cell transplant, stomatitis. Busulfex dosage: 160 MG, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, METHOTREXATE, LEUCOVORIN CALCIUM, FILGRASTIM. Patient recovered.Busulfex Side Effects Report #5895530-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 10, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood bilirubin increased, bone marrow transplant
, sepsis . Busulfex dosage: 25.2 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5955102-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2008. Female patient, 57 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, candida sepsis, cytomegalovirus viraemia, disseminated intravascular coagulation, histiocytosis haematophagic, nausea
, stem cell transplant, stomatitis. Busulfex dosage: 160 MG, DAILY DOSE INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, THYMOGLOBULIN, CYCLOSPORINE, FILGRASTIM, METHOTREXATE, LEUCOVORIN CALCIUM. Patient died.Busulfex Side Effects Report #5698164-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 56 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, cystitis viral, cytomegalovirus antigen positive, cytomegalovirus viraemia, diarrhoea, enterococcal sepsis, hepatic function abnormal, nausea
. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5698189-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 56 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, blood urea increased, encephalitis herpes, gamma-glutamyltransferase increased, nausea
, sepsis . Busulfex dosage: 20.1 ML INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5729839-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, altered state of consciousness, anorexia, cytomegalovirus infection
, disease recurrence, disseminated intravascular coagulation, encephalitis , encephalopathy, malaise. Busulfex dosage: 18 ML, INTRAVENOUS; 24 ML, INTRAVENOUS; 6 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, NARTOGRASTIN, NEUPOGEN, LENOGRASTIM, METHOTREXATE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5744160-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on May 08, 2008. Female patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, bone marrow transplant rejection, cytomegalovirus infection
, disseminated intravascular coagulation, encephalitis viral, gamma-glutamyltransferase increased. Busulfex dosage: 18 ML, INTRAVENOUS; 24 ML, INTRAVENOUS; 6 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, NARTOGRASTIN, NEUPOGEN, LENOGRASTIM, METHOTREXATE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5744162-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on May 08, 2008. Female patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, alanine aminotransferase increased, anorexia, blood bilirubin increased, bone marrow transplant
, bone marrow transplant rejection, gastrointestinal haemorrhage, nausea , platelet count decreased. Busulfex dosage: 30 ML, INTRAVENOUS. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5877535-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Female patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood potassium decreased, blood sodium decreased, bone marrow transplant rejection, malaise, nausea
, transplant failure. Busulfex dosage: 192 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5888695-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 30, 2008. Female patient, 55 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, arthritis bacterial, bone marrow transplant rejection, cardiac failure, chronic graft versus host disease, convulsion, cytomegalovirus viraemia. Busulfex dosage: 10.6 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Busulfex Side Effects Report #5984856-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Female patient, 54 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, blood potassium decreased, blood sodium decreased, blood urea increased, blood uric acid increased, cytomegalovirus enterocolitis, diarrhoea, lung infection pseudomonal. Busulfex dosage: 156 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FLGRASTIM, CYCLOSPORINE. Patient was hospitalized. Patient died on 03/30/2008.
Busulfex Side Effects Report #5809452-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, malignant neoplasm progression, nausea
, pneumonia , staphylococcal sepsis, stem cell transplant, stomatitis. Busulfex dosage: 7.5 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient died on 08/15/2007.Busulfex Side Effects Report #5811572-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 01, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, malaise, peritonsillitis, stomatitis. Busulfex dosage: 32 ML, DAILY DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfex Side Effects Report #5886250-6
Busulfex side effect was reported by a Health Professional from JAPAN on Sept 01, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, bone marrow transplant
, diarrhoea, headache , malaise, nausea , pain in extremity. Busulfex dosage: 12 ML, INTRAVENOUS; 24 ML, DAILY: INTRAVENOUS; DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5893733-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2008. Female patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, hyperglycaemia, klebsiella sepsis, liver disorder, malaise, nausea
, pneumonia klebsiella. Busulfex dosage: 27.2 ML, INTRAVENOUS. During the same period patient was treated with CYCLOSPORINE, FLUDARABINE PHOSPHATE, VALPROATE, NARTOGRASTIM, METHOTREXATE, METHYLPREDNISOLONE. Patient died.Busulfex Side Effects Report #5989585-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 20, 2008. Male patient, 53 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cytomegalovirus viraemia, diarrhoea, febrile neutropenia, hepatic function abnormal, hyperkalaemia, hyponatraemia, malaise, nausea
. Busulfex dosage: 8 ML, TID. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, NEUTROGIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5729830-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: adenoviral haemorrhagic cystitis, anorexia, blood potassium decreased, engraft failure, malaise, nausea
, pharyngeal oedema, pneumonia bacterial, pulmonary haemorrhage. Busulfex dosage: 26.8 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, MITOXANTRONE, PHENYTOIN, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5819583-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bone marrow transplant
, catheter sepsis, convulsion, cystitis haemorrhagic, diarrhoea. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FLIGRASTIM, METHOTREXATE, TACROLIMUS, MYOPHENOLATE MOFETIL, MICAFUNGIN, GANCICLOVIR. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5839351-2
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 30, 2008. Female patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, diarrhoea, engraftment syndrome, enterococcal sepsis, hallucination, hyperuricaemia, multi-organ failure, nausea
. Busulfex dosage: 26.8 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient was hospitalized and became disabled. Patient died on 08/11/2007.Busulfex Side Effects Report #5886248-8
Busulfex side effect was reported by a Health Professional from JAPAN on Aug 30, 2008. Male patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood sodium decreased, bone marrow transplant rejection. Busulfex dosage: 30 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.
Busulfex Side Effects Report #5984857-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Female patient, 52 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: adult t-cell lymphoma/leukaemia recurrent, anorexia, bone marrow transplant
, cytomegalovirus viraemia, diarrhoea, hypokalaemia, malaise, nausea . Busulfex dosage: 6.4 ML, QD. During the same period patient was treated with DEPAKENE, FLUDARABINE PHOSPHATE, FILGRASTIM. Patient recovered.Busulfex Side Effects Report #5819606-8
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Male patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, cystitis haemorrhagic, diarrhoea, malaise, malignant neoplasm progression, nausea
, stem cell transplant, stomatitis. Busulfex dosage: 24 ML, DAILY DOSE INTRAVENOUS; 32 ML, DAILY DOSE; INTRAVENOUS; 8 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died on 08/26/2007.Busulfex Side Effects Report #5888694-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant rejection, diarrhoea, febrile neutropenia, malaise, malignant neoplasm progression, nausea
. Busulfex dosage: 25.88 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5893732-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2008. Female patient, 51 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, adult t-cell lymphoma/leukaemia recurrent, anorexia, bone marrow transplant
, cytomegalovirus enterocolitis, malaise, stomatitis, vomiting. Busulfex dosage: 24 ML, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5786820-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 09, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bronchopulmonary aspergillosis, catheter sepsis, diarrhoea, hepatic failure, hyperglycaemia, hypoalbuminaemia, malaise. Busulfex dosage: 38 ML. During the same period patient was treated with CYCLOPHOSPHAMIDE, THIOPETA, PHENYTOIN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died.
Busulfex Side Effects Report #5798829-0
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Female patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, cytomegalovirus viraemia, enterocolitis, graft versus host disease, malaise, multi-organ failure, myelodysplastic syndrome. Busulfex dosage: 32 ML, INTRAVENOUS; 16 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, MELPHALAN, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5818265-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bacterial sepsis, diarrhoea, enterococcal sepsis, nausea
, stomatitis. Busulfex dosage: 153 MG, DAILY DOSE, INTRAVENOUS ; 204 MG, DAILY DOSE; INTRAVENOUS; 51 MG, DAILY DOSE; INTRAVENO. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient recovered.Busulfex Side Effects Report #5883704-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, diarrhoea, hiccups, malaise, nausea
, neutropenia, oedema, rash . Busulfex dosage: 24.6 ML, INTRAVENOUS; 32.8 ML, DAILY DOSE; INTRAVENOUS; 8.2 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5958872-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 04, 2008. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, cytomegalovirus viraemia, diarrhoea, hiccups, malaise, nausea
, neutropenia, oedema. Busulfex dosage: 8.2 ML, TID INTRAVENOUS; 8.2 ML, QID; INTRAVENOUS; 8.2 ML, QD; INTRAVENOUS. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized and became disabled. Patient died.Busulfex Side Effects Report #5974411-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 17, 2008. Female patient, 50 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal pain
, acute graft versus host disease, acute myeloid leukaemia, anorexia, bone marrow transplant , constipation , diarrhoea, febrile neutropenia, headache . Busulfex dosage: 6.67 ML, QID INTRAVENOUS. During the same period patient was treated with ENDOXAN NET, METHOTREXATE, DEPAKENE, FILGRASTIM, TACROLIMUS. Patient was hospitalized. Patient died on 06/16/2007.Busulfex Side Effects Report #5818264-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Female patient, child 5 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, convulsion, diarrhoea, graft versus host disease, grand mal convulsion. Busulfex dosage: 11.2 ML, DAILY DOSE. During the same period patient was treated with CYCLOPHOSPHAMIDE, PHENYTOIN, FILGRASTIM, CYCLOSPORINE, METHYLPREDNISOLONE. Patient recovered.
Busulfex Side Effects Report #5819591-9
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2008. Male patient, 49 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, graft versus host disease, jaundice
, malaise, nausea , stomatitis. Busulfex dosage: 24 ML; 32 ML, DAILY DOSE; INTRAVENOUS; 8 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, FILGRASTIM, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5883703-1
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 27, 2008. Male patient, 48 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal pain
, acute graft versus host disease, anorexia, bone marrow transplant rejection, cytomegalovirus infection , diarrhoea, engraft failure, hepatic function abnormal, malaise. Busulfex dosage: 38.92 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, LENOGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient recovered.Busulfex Side Effects Report #5886249-X
Busulfex side effect was reported by a Health Professional from JAPAN on Sept 03, 2008. Female patient, 48 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, graft versus host disease, malaise, nausea
, renal disorder. Busulfex dosage: 27.72ML INTRAVENOUS. During the same period patient was treated with GANCICLOVIR, FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient died.Busulfex Side Effects Report #5809439-0
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2008. Male patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, bone marrow transplant rejection, liver disorder, liver function test abnormal, nausea
, platelet count decreased, pneumonia . Busulfex dosage: unknown. During the same period patient was treated with NEUPOGEN, METHOTREXATE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, PHENYTOIN. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5819511-7
Busulfex side effect was reported by a Health Professional from JAPAN on July 08, 2008. Female patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant
, diarrhoea, gastrointestinal haemorrhage, malaise, multi-organ failure, nausea . Busulfex dosage: 6 ML INTRAVENOUS; 24 ML, DAILY DOSE; INTRAVENOUS; 18 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #5888928-7
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2008. Male patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, diarrhoea, hyperuricaemia, malaise. Busulfex dosage: 42 ML, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient died on 02/26/2008.
Busulfex Side Effects Report #5979847-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Female patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, ascites, diarrhoea, gastrointestinal haemorrhage, malaise, multi-organ failure, nausea
. Busulfex dosage: 6 ML, DAILY DOSE, INTRAVENOUS; 6 ML, QID, INTRAVENOUS; 6 ML, TID, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient died.Busulfex Side Effects Report #6076410-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Jan 27, 2009. Female patient, 47 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, ascites, diarrhoea, gastrointestinal haemorrhage, malaise, multi-organ failure, nausea
. Busulfex dosage: 6 ML, DAILY DOSE INTRAVENOUS ; 6 ML, QID, INTRAVENOUS ; 6 ML, TID, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient died on 07/03/2007.Busulfex Side Effects Report #5743640-X
Busulfex side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: altered state of consciousness, anaemia, anorexia, blood pressure decreased, bone marrow transplant rejection, diarrhoea, febrile neutropenia, hyperbilirubinaemia, malaise. Busulfex dosage: 40 ML. During the same period patient was treated with CYCLOSPORINE, HYDROXYCARBAMIDE, FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, METHOTREXATE. Patient died.
Busulfex Side Effects Report #5822823-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on July 14, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, anorexia, convulsion, diarrhoea, graft versus host disease, malaise, nausea
, staphylococcal sepsis, stomatitis. Busulfex dosage: 27 ML, INTRAVENOUS, 36 ML DAILY DOSE; INTRAVENOUS, 9 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, LENOGRASTIM, TACROLIMUS, CYTARABINE. Patient was hospitalized. Patient died on 08/29/2007.Busulfex Side Effects Report #5862345-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 12, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, enterocolitis, hyponatraemia, malaise, nausea
, renal failure acute, stomatitis. Busulfex dosage: 40 ML. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5920081-3
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Sept 30, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, bone marrow transplant rejection, cytomegalovirus infection
, gastrointestinal ulcer, gastrointestinal ulcer haemorrhage, liver function test abnormal, malaise, nausea , stem cell transplant. Busulfex dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, PHENYTOIN, FILGRASTIM, METHOTREXATE, CYCLOSPORINE. Patient died on 12/08/2006.Busulfex Side Effects Report #5798834-4
Busulfex side effect was reported by a Health Professional from JAPAN on June 16, 2008. Female patient, 45 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, leukaemia recurrent, leukocytosis, malaise, nausea
, oral disorder. Busulfex dosage: 5.3 ML INTRAVENOUS; 21.2 ML, DAILY DOSE; INTRAVENOUS; 15.9 ML, DAILY DOSE; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, TACROLIMUS. Patient died on 04/14/2007.Busulfex Side Effects Report #5878609-8
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, constipation
, diarrhoea, encephalitis viral, jaundice , malaise, nausea , oropharyngeal pain, pruritus. Busulfex dosage: 26.8 ML, DAILY DOSE INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died.Busulfex Side Effects Report #5979833-6
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 13, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: abdominal discomfort, anorexia, constipation
, diarrhoea, encephalitis herpes, jaundice , malaise, nausea , oropharyngeal pain. Busulfex dosage: 26.8 ML, DAILY DOSE, INTRAVENOUS. During the same period patient was treated with MELPHALAN, TACROLIMUS. Patient died on 11/10/2007.Busulfex Side Effects Report #5979835-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 12, 2008. Female patient, 44 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood urea increased, jaundice
, malaise, sepsis , stomatitis. Busulfex dosage: 30 MG, QID, INTRAVENOUS. During the same period patient was treated with DEPAKENE, CYCLOPHOSPHAMIDE, METHOTREXATE, TACROLIMUS, METHYLPREDNISOLONE, CELLCEPT USA. Patient died on 07/16/2007.Busulfex Side Effects Report #5729835-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2008. Female patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, diarrhoea, febrile neutropenia, malaise, meningitis
, stem cell transplant. Busulfex dosage: 28.28 ML INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, CYCLOSPORINE, IRINOTECAN. Patient was hospitalized. Patient recovered.Busulfex Side Effects Report #5878610-4
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Aug 26, 2008. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, diarrhoea, haemodialysis, hepatic function abnormal, malaise, meningitis viral. Busulfex dosage: 36 ML, INTRAVENOUS. During the same period patient was treated with LENOGRASTIM, FILGRASTIM, FLUDARABINE PHOSPHATE, VALPROATE, TACROLIMUS. Patient died.
Busulfex Side Effects Report #5974410-5
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Nov 18, 2008. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, bone marrow transplant rejection, cellulitis
, cerebral haemorrhage, convulsion, cystitis haemorrhagic, depressed level of consciousness, histiocytosis haematophagic. Busulfex dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, FILGRASTIM, METHOTREXATE. Patient died on 11/10/2007.Busulfex Side Effects Report #6016154-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 09, 2008. Female patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, chronic graft versus host disease, diarrhoea, hyponatraemia, malaise, pharyngitis, stomatitis. Busulfex dosage: 22 ML INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE. Patient died on 08/31/2008.
Busulfex Side Effects Report #6030744-X
Busulfex side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2008. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with Busulfex. After drug was administered, patient experienced the following side effects: acute graft versus host disease, anorexia, bone marrow transplant rejection, cellulitis
, cerebral haemorrhage, convulsion, cystitis haemorrhagic, cytomegalovirus viraemia, depressed level of consciousness. Busulfex dosage: 45 MG, QID INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, FILGRASTIM, METHOTREXATE. Patient died on 11/10/2007.